Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neogenomics Inc
(NQ:
NEO
)
14.88
-0.20 (-1.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
833,547
Open
15.47
Bid (Size)
13.00 (1)
Ask (Size)
15.84 (1)
Prev. Close
15.08
Today's Range
14.66 - 15.51
52wk Range
11.03 - 21.22
Shares Outstanding
122,816,314
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
July 09, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
June 13, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Performance
YTD
-6.71%
-6.71%
1 Month
+11.54%
+11.54%
3 Month
-2.23%
-2.23%
6 Month
-9.27%
-9.27%
1 Year
-13.79%
-13.79%
More News
Read More
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
May 28, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics Earnings Analysis: Q1 Recap
May 10, 2024
Via
Benzinga
Where NeoGenomics Stands With Analysts
April 30, 2024
Via
Benzinga
What 6 Analyst Ratings Have To Say About NeoGenomics
March 18, 2024
Via
Benzinga
NEO Stock Earnings: NeoGenomics Beats EPS, Beats Revenue for Q1 2024
April 30, 2024
Via
InvestorPlace
NeoGenomics Reports First Quarter 2024 Results
April 30, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics Announces Senior Leadership Promotions
April 18, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
April 09, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Evaluating NeoGenomics: Insights From 4 Financial Analysts
February 21, 2024
Via
Benzinga
Recap: NeoGenomics Q4 Earnings
February 20, 2024
Via
Benzinga
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
March 27, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
March 20, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Earnings Scheduled For March 15, 2024
March 15, 2024
Via
Benzinga
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
March 01, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know
February 22, 2024
Via
Benzinga
NeoGenomics Stock Surged But Technicals Point To A Pullback
February 22, 2024
Via
Talk Markets
Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?
February 21, 2024
Via
Benzinga
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
February 21, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 21, 2024
Via
Benzinga
Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
February 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 21, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 21, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.